Classification
Product TypeProcessed Food
Product FormDietary supplement (oral; e.g., effervescent tablet, tablet, gummy)
Industry PositionConsumer Packaged Goods — Food Supplement
Market
Vitamin C supplements in Brazil are regulated as “suplementos alimentares” under ANVISA’s food-supplement framework, with permitted constituents, use limits, and labeling/claims controls anchored in RDC 243/2018 and related normative lists. The market is supplied by a mix of multinational and domestic brands, including vitamin C effervescent products sold through pharmacies/drugstores and direct-to-consumer online storefronts. Imports of products subject to sanitary surveillance typically flow through Siscomex with ANVISA’s prior administrative control (non-automatic licensing), making regulatory readiness and documentation quality central to lead times. Enforcement actions (including recalls and sales prohibitions) highlight that weak GMP-style controls, missing stability evidence, or lack of ANVISA regularization can disrupt availability and create reputational risk for importers and brands.
Market RoleDomestic consumer market with local branded supply; import-dependent for some finished SKUs and for upstream vitamin C inputs used in local manufacturing
Domestic RoleRetail supplement category positioned around immunity and antioxidant claims permitted within ANVISA’s supplement rules
Risks
Regulatory Compliance HighNon-compliance with ANVISA’s supplement rules (RDC 243/2018) and the permitted-constituent/limits/claims lists (e.g., IN 28/2018 as updated) can block import clearance, trigger stop-sale orders, or lead to recall/prohibition actions.Pre-validate formula, daily dose, claims, and label text against RDC 243/2018 and the current ANVISA normative lists; run a pre-shipment dossier and label review with the importer’s ANVISA compliance lead before booking freight.
Food Safety HighANVISA has ordered recalls and suspended manufacturing/sales for supplements due to serious GMP and quality-system failures (including deficient cleaning, poor segregation, weak records, missing allergen control, and missing stability studies), which can abruptly disrupt supply and trigger reputational exposure for brands and importers.Qualify suppliers with GMP/BPF audits, require stability evidence for the finished format (especially effervescent/gummy), and maintain robust batch records and complaint/recall readiness.
Logistics MediumImports of products under sanitary surveillance may require non-automatic licensing in Siscomex with prior ANVISA analysis, creating a delay risk if documentation, product regularization information, or classification is incomplete or inconsistent.Use an importer-of-record experienced with ANVISA/Siscomex workflows, ensure NCM/product descriptions are consistent across documents, and maintain a standardized document pack (LI fields, product regularization references, CoA).
Illicit Trade MediumIrregular supplements marketed without proper ANVISA regularization (including online sales with missing manufacturer/importer identification) can create brand and channel risk and lead to enforcement actions that remove products from the market.Monitor online channels for unauthorized listings, use authorized distribution agreements, and provide consumers with verification guidance (official channels and compliant labeling).
Sustainability LowPackaging compliance expectations under PNRS can affect material choices and reverse-logistics planning for consumer supplement packaging in Brazil.Align packaging materials and labeling with PNRS-related compliance needs and implement reverse-logistics arrangements where required by local rules and sector agreements.
Sustainability- Consumer packaging waste compliance expectations under Brazil’s National Solid Waste Policy (PNRS), including reverse-logistics/EPR-related obligations that can affect packaging design and post-consumer responsibilities.
Labor & Social- Consumer harm and reputational risk from irregular/clandestine supplements sold via online channels; importer/brand due diligence is important to avoid association with non-regularized products.
Standards- BPF/POPs (GMP-style prerequisite programs) aligned with ANVISA RDC 275/2002 for food establishments
FAQ
Which authority regulates vitamin C supplements in Brazil?ANVISA (Agência Nacional de Vigilância Sanitária) regulates food supplements in Brazil, including vitamin C supplement products, under the supplement framework set by RDC 243/2018 and related normative lists that define permitted constituents, limits, and labeling/claims conditions.
Why can vitamin C supplement imports face clearance delays in Brazil?If the product is subject to sanitary surveillance controls, the import process may require non-automatic licensing in Siscomex with prior ANVISA analysis. Delays commonly arise from incomplete or inconsistent documentation, product regularization information, or classification details in the import filing.
What quality issues have triggered ANVISA actions against supplements recently?ANVISA has reported enforcement actions including recalls and suspension of manufacturing/sales when inspections found serious failures in manufacturing and quality systems, such as inadequate hygiene/cleaning in critical areas, poor segregation and storage, weak quality records, missing allergen control measures, and lack of stability studies to support shelf-life.